MTOR and cancer: As Food and Drug Administration-approved inhibitors of mammalian target of rapamycin (mTOR) kinase, these macrolide compounds are used therapeutically to inhibit the processes of cancer, autoimmunity, graft versus host disease, atherosclerosis, and aging [21].